Clovis Oncology announces proposed offering of common stock
Clovis Oncology announced it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $275 million. J. P. Morgan Securities is acting as lead book-running manager and representative of the underwriters for the offering. July 07, 2015